Mutational analysis in Lebanese patients with congenital adrenal hyperplasia due to a deficit in 21-hydroxylase

Hormone Research

Volumn 53, Issue 2, 2000, Pages 77-82

  Delague, Valérie ^a   Souraty, Noëlle ^a   Khallouf, Eliane ^b   Tardy, Véronique ^c   Chouery, Eliane ^a   Halaby, Georges ^b   Loiselet, Jacques ^a   Morel, Yves ^c   Mégarbané, André ^a,d  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b SAINT JOSEPH UNIVERSITY   (Lebanon)

^c HÔPITAL DEBROUSSE   (France)

^d St Joseph Hospital   (France)

Author keywords

21 Hydroxylase; 8 bp deletion; Lebanese; Mutations; Screening

Indexed keywords

STEROID 21 MONOOXYGENASE;

ADOLESCENT; ADULT; ARTICLE; BIODIVERSITY; CHILD; CLINICAL FEATURE; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; INFANT; INTRON; MAJOR CLINICAL STUDY; MALE; NEWBORN; POINT MUTATION; PRIORITY JOURNAL; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROIDOGENESIS;

EID: 0033818852     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023518     Document Type: Article

References (23)

1. White PC, New MI, Dupont B: CAH. N Engl J Med 1987;316:1519-1524.
2. Morel Y, Miller WL: Clinical and molecular genetics of CAH due to 21-hydroxylase deficiency. Adv Hum Genet 1991;20:1-68.
3. Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI: High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985;37:65-67.
4. Donohoue PA, Dop C van, McLean RH, White PC, Jospe N, Migeon CJ: Gene conversion in salt-losing CAH with absent complement C4B protein. J Clin Endocrinol Metab 1986;62: 995-1002.
5. Krawczak M, Cooper DN: The human gene mutation. Trends Genet 1997;13:121-122.
6. Der Kaloustian VM, Naffah J, Loiselet J: Genetic diseases in Lebanon. Am J Hum Genet 1980;7:187-203.
7. Morel Y, Tardy V: Molecular genetics of 21-hydroxylase deficiency; in Azziz R, Nestler JE, Dewailly D (eds): Androgen Excess Disorders in Women. Philadelphia, Lippincott-Raven. 1997, vol 16, pp 159-172.
8. Miller SA, Dynes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988;16: 1215.
9. Ghanem N, Uring-Lambert B, Abbal M, Hauptmann G, Lefranc MP, Lefranc G: Polymorphism of MHC classIII genes: definition of restriction fragment linkage groups and evidence for frequent deletions and duplications. Hum Genet 1988;79:209-218.
10. Portrat-Doyen S, Tourniaire J, Richard O, Mulatero P, Aupetit-Faisant B, Curnow KM, Pascoe L, Morel Y: Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab 1998;83:4156-4161.
11. Day DJ, Speiser PW, Schulze E, Bettendorf M, Fitness J, Barany F, White PC: Identification of non-amplifying genes when using PCR-based diagnosis of 21 hydroxylase deficiency in CAH (CAH) affected pedigrees. Hum Mol Genet 1996;5:2039-2048.
12. Witchel SF, Bhamidipati DK, Hoffman EP, Cohen JB: Phenotypic heterogeneity associated with the splicing mutation in CAH due to 21-hydroxylase deficiency. J Clin Endocr Metab 1996;81:4081-4088.
13. Owerbach D, Crawford YM, Draznin MB: Direct analysis of CYP21B in 21-hydroxylase deficiency using PCR reaction amplification. Mol Endocrinol 1990;4:125-131.
14. Mornet E, Crete P, Kutten F, Roux-Demay MC, Bau J, White PC, Bom A: Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet 1991;48:79-88.
15. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna M, Lesser M, New MI, White PC: Disease expression and molecular genotype in CAH due to 21-hydroxylase deficiency. J Clin Invest 1992;90:584-595.
16. Morel Y, Andre J, Uring-Lambert B, Hauptmann G, Betuel H, Meo T, Forest MG, David M. Bertrand J, Miller WL: Rearrangements and point mutations of P450c21 gene are distinguished by five haplotypes in 57 families with CAH. J Clin Invest 1989;83:527-536.
17. Barbat B, Bogyo A, Raux-Demay MC, Kuttenn F, Boue J, Simon-Bouy B, Serre JL, Mornet E: Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency. Hum Mutat 1995;5:126-130.
18. Levo A, Partanen J: Mutation-haplotype analysis of steroid 21-hydroxylase (CYP21) deficiency in Finland: Implications for the population history of defective alleles. Hum Genet 1997; 99:488-497.
19. Lobato MN, Aledo R, Meseguer A: High variability of CYP21B gene rearrangements in Spanish patients with classic form of CAH. Hum Hered 1998;48:216-225.
20. Bobba A, Marra E, Giannattasio S, Iolascon A, Monno F, Di Maio S: 21-Hydroxylase deficiency in Italy: A distinct distribution pattern of CYP21 mutations in a sample from southern Italy. J Med Genet 1999;36:648-650.
21. Lobato MN, Ordonez-Sanchez ML, Tusié-Luna MT, Meseguer A: Mutation analysis in Patients with CAH in the Spanish population: Identification of putative novel steroid 21-hydroxylase deficiency alleles associated with the classic form of the disease. Hum Hered 1999;49:169-175.
22. Dardis A, Bergada I, Bergada C, Rivarola M, Belgorosky A: Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical CAH. J Pediatr Endocrinol Metab 1997;10:55-61.
23. Kapelari K, Ghanaati Z, Wollmann H, Ventz M, Ranke MB, Kofler R, Peters H: A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia. Hum Mut 1999;13:505.